ADHD is a common condition that can significantly affect a child’s education and future if not diagnosed and managed promptly. In the UK, ADHD diagnosis often takes too long due to reliance on input from parents, teachers, and clinicians, contributing to long waiting lists and delays.

The QbTest is an innovative medical device developed by QbTech Ltd that uses computerized tasks and motion-sensing technology to measure attention, impulsivity, and activity levels—the key symptoms of ADHD. It allows clinicians to make quicker and more accurate diagnoses, helping to cut waiting times by up to 50% and saving the NHS an estimated £1.9 million annually.

The QbTest is approved for use in the U.S., supported by UK health guidelines, and has been recognized for its international excellence. Researchers are working to expand its adoption across the UK and exploring its potential for diagnosing autism.